Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Hyun Cho

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Neurology|September 15, 2020
Association between <i>APOE</i> ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairmentJin San Lee, Hyejoo Lee, Seongbeom Park, et al.
Alzheimer'S Research & Therapy|January 6, 2020
Clinical significance of focal ß-amyloid deposition measured by <sup>18</sup>F-flutemetamol PETSi Eun Kim, Byungju Lee, Seongbeom Park, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Clinical Effects of Frontal Behavioral Impairment: Cortical Thickness and Cognitive Decline in Individuals with Subjective Cognitive Decline and Amnestic Mild Cognitive ImpairmentSeung Joo Kim, Na-Yeon Jung, Young Ju Kim, et al.
Neurobiology of Aging|December 1, 2019
Differences in neuroimaging features of early- versus late-onset nonfluent/agrammatic primary progressive aphasiaJin San Lee, Sole Yoo, Seongbeom Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 6, 2025
Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profilesDaeun Shin, Hyemin Jang, Heejin Yoo, et al.
Psychiatry Investigation|January 18, 2022
Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer's Disease Study: BICWALZSHyun Woong Roh, Na-Rae Kim, Dong-Gi Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 1, 2019
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patientsHyemin Jang, Hee Jin Kim, Seongbeom Park, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2025
South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trialSo Young Moon, Yoo Kyoung Park, Jee Hyang Jeong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2025
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnosticsHyemin Jang, Daeun Shin, Heejin Yoo, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 26, 2026
Cellular Senescence of Patient-derived Fibroblasts Reveals the Mid-old Stage as a Critical Window for Transcriptomic Signatures Linked to Alzheimer's Disease Biomarkers and ClassificationYoung Joon Cho, Sunwoo Yoon, Yeojin Kim, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Neurology|September 15, 2020
Association between <i>APOE</i> ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairmentJin San Lee, Hyejoo Lee, Seongbeom Park, et al.
Alzheimer'S Research & Therapy|January 6, 2020
Clinical significance of focal ß-amyloid deposition measured by <sup>18</sup>F-flutemetamol PETSi Eun Kim, Byungju Lee, Seongbeom Park, et al.
Journal of Alzheimer'S Disease : JAD|April 9, 2019
Clinical Effects of Frontal Behavioral Impairment: Cortical Thickness and Cognitive Decline in Individuals with Subjective Cognitive Decline and Amnestic Mild Cognitive ImpairmentSeung Joo Kim, Na-Yeon Jung, Young Ju Kim, et al.
Neurobiology of Aging|December 1, 2019
Differences in neuroimaging features of early- versus late-onset nonfluent/agrammatic primary progressive aphasiaJin San Lee, Sole Yoo, Seongbeom Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 6, 2025
Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profilesDaeun Shin, Hyemin Jang, Heejin Yoo, et al.
Psychiatry Investigation|January 18, 2022
Baseline Clinical and Biomarker Characteristics of Biobank Innovations for Chronic Cerebrovascular Disease With Alzheimer's Disease Study: BICWALZSHyun Woong Roh, Na-Rae Kim, Dong-Gi Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 1, 2019
Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patientsHyemin Jang, Hee Jin Kim, Seongbeom Park, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2025
South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trialSo Young Moon, Yoo Kyoung Park, Jee Hyang Jeong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2025
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnosticsHyemin Jang, Daeun Shin, Heejin Yoo, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 26, 2026
Cellular Senescence of Patient-derived Fibroblasts Reveals the Mid-old Stage as a Critical Window for Transcriptomic Signatures Linked to Alzheimer's Disease Biomarkers and ClassificationYoung Joon Cho, Sunwoo Yoon, Yeojin Kim, et al.
Pageof 19